01 Stock Market
The U.S. major indexes closed as follows: Dow Jones up 2.49% at 46,341.51; S&P 500 up 2.91% at 6,528.52; NASDAQ up 3.83% at 21,590.63. The trio logged their strongest single-day rally in weeks as investors rushed into technology, semiconductor and biotech names on a wave of deal news and easing geopolitical angst.
Chipmakers, megacaps and high-beta ETFs led the charge. Nvidia (NVDA) jumped 5.59% at $174.40 after unveiling a $2 billion stake in Marvell; Marvell (MRVL) soared 12.80% at $99.05 on the partnership. Memory giant Micron (MU) climbed 4.98% at $337.84, while Intel (INTC) rose 7.14% at $44.13 and TSMC (TSM) advanced 6.78% at $337.95. EV bellwether Tesla (TSLA) gained 4.64% at $371.75, and leveraged fund SOXL shot up 17.95% at $47.91, underscoring risk-on appetite. Social-media name Snap (SNAP) rallied about 8% on activist headlines, while Meta (META) leapt 6.67% at $572.13. Semiconductor designer AMD (AMD) added 3.77% at $203.43, and Chinese EV maker NIO (NIO) surged 9.44% at $6.03.
M&A fireworks lit up the tape. Biotech firm Apellis Pharmaceuticals catapulted more than 130% after agreeing to a $5.6 billion buyout from Biogen, while news of activist pressure propelled Snap and financing breakthroughs lifted AI-infrastructure players such as CoreWeave. The confluence of blockbuster deals and fresh capital for next-generation computing reinforced expectations that corporate spending on artificial-intelligence capabilities will stay robust, helping the S&P 500 notch its best start to a quarter since early 2023.
02 Other Markets
U.S. 10-year Treasury yield rose by 0.18%, latest at 4.32%. USD/CNH rose 0.02%, at 6.90; USD/HKD fell 0.01%, at 7.84. U.S. Dollar Index fell 0.02%, at 99.84. WTI crude futures rose 0.79%, at 102.18 USD/bbl; COMEX gold futures rose 0.64%, at 4,708.60 USD/oz.
03 Top News
1. Biogen Agrees To Acquire Apellis In A $5.6 Billion Cash Deal. The purchase hands Biogen two approved drugs, including eye-disease therapy Syfovre, as it seeks new growth drivers beyond multiple sclerosis treatments. Apellis shares skyrocketed more than 130%, while Biogen slipped modestly on funding concerns.
2. Nvidia Invests $2 Billion In Marvell To Deepen AI Collaboration. The funding secures Marvell’s custom chip and networking technology for Nvidia’s NVLink Fusion ecosystem. Both firms will co-develop optical interconnects and silicon-photonics solutions aimed at accelerating data-center AI workloads.
3. Activist Fund Irenic Capital Builds 2.5% Stake In Snap And Presses For Restructuring. In a letter to CEO Evan Spiegel, Irenic urged cost cuts and a potential spin-off of Snap’s Spectacles unit, arguing the moves could push the share price above $26. Snap acknowledged ongoing dialogue with investors as its stock jumped about 8%.
4. CoreWeave Secures $8.5 Billion Investment-Grade Loan To Expand Cloud GPU Infrastructure. The oversubscribed delayed-draw facility, arranged by major banks and anchored by Blackstone, lets CoreWeave fund high-performance computing projects through 2032. Moody’s and DBRS assigned investment-grade ratings, underscoring lender confidence in AI-driven demand.
5. Nebius Unveils 310 MW AI Factory In Finland, Creating 700 Construction Jobs. The planned Lappeenranta site will be among Europe’s largest dedicated AI facilities and will use closed-loop liquid cooling with heat-recovery integration. Nebius now targets more than 3 GW of contracted power across EMEA by 2026.
6. Iran’s Revolutionary Guards Threaten To Strike U.S. Tech Giants Operating In The Region. An IRGC statement listed firms such as Microsoft, Google, Apple, Intel and Tesla as potential targets in retaliation for attacks on Iran. The warning heightens geopolitical risk for multinationals with Middle-East assets.
7. White House Signals Readiness To End Iran Conflict Without Reopening Strait Of Hormuz. Officials said President Trump is prepared to wind down military operations once Iran’s offensive capacity is degraded, even if the key oil waterway remains restricted. Energy markets pared risk premiums on hopes of de-escalation.
8. T1 Energy Posts Unexpected Loss, Sending Shares Down Over 17%. The oil-services firm reported a $(0.70) per-share loss versus an expected $0.02 profit as project delays hit revenue, which fell 10.7% below consensus. Management is reviewing capital spending to stabilize margins.
9. Eli Lilly Reaches $6.3 Billion Deal To Buy Centessa Pharmaceuticals. The takeover adds experimental sleep-disorder treatments to Lilly’s pipeline, complementing its fast-growing obesity portfolio. Centessa’s U.S. shares soared roughly 50% after the announcement.
10. Microsoft Commits Over $1 Billion To Build Cloud And AI Infrastructure In Thailand. The project includes new data-center capacity and workforce training programs aimed at meeting Southeast Asia’s surging demand for generative-AI services. Analysts view the move as a strategic push to cement Azure’s regional footprint.
Sources: Reuters, Dow Jones, Tiger Newspress, public market data Disclaimer: This content is for reference only and does not constitute investment advice.
